SCHEMBL6986243

SCHEMBL6986243

CN(C(=O)c1ccc2c(c1)CCCN2)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.62
MAPT P10636 2/20 0.62
L3MBTL1 Q9Y468 2/20 0.50
POLB P06746 1/20 0.50
KMT2A Q03164 1/20 0.47
PLAU P00749 2/20 0.46
ACHE P22303 2/20 0.45
ALDH1A1 P00352 2/20 0.45
HTT P42858 2/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
GAA P10253 1/20 0.45
THRB P10828 1/20 0.45
ALOX15 P16050 1/20 0.45
CASP1 P29466 1/20 0.45
CASP7 P55210 1/20 0.45
HSD17B10 Q99714 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
NPC1 O15118 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL45780 0.84 KDM4E (0.68) KDM4EMAPTPLAUACHEALDH1A1
SCHEMBL6983698 0.77 KDM4E (0.62) KDM4EMAPTPLAUACHEALDH1A1
SCHEMBL29673258 0.77 KDM4E (1.00) KDM4EMAPTPLAUACHEALDH1A1
SCHEMBL45202 0.77 KDM4E (1.00) KDM4EMAPTPLAUACHEALDH1A1
SCHEMBL3096482 0.76 MAPT (0.73) KDM4EMAPTPLAUACHEALDH1A1
SCHEMBL21499389 0.75 NR1H4 (0.52) KDM4EMAPTPLAUACHEALDH1A1
SCHEMBL8511891 0.75 KDM4E (0.54) KDM4EMAPTACHEALDH1A1ALOX15
SCHEMBL30011603 0.73 KDM4E (0.73) KDM4EMAPTPLAUACHEALDH1A1
SCHEMBL28039955 0.73 MAPT (0.73) KDM4EMAPTPLAUACHEALDH1A1
SCHEMBL12486871 0.73 KDM4E (0.73) KDM4EMAPTPLAUACHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed